unique role in the head-injured patient, ephasises the need for improved access to scanners. In the interest of the patients the pattern of service must change.
region in 1974) the scanner could remove the fear that a treatable lesion may be missed or recognised too late. This is of particular interest at a time when high-cost technology medicine requires justification. Fineberg et a14 proposed standards by which a new piece of medical technology should be judged, and his criteria have been developed and adopted by the American Medical Association for its policy on CAT scanning. There are five levels of efficiency: (a) technical capability, whether the apparatus provides an accurate representation of the area scanned; (b) diagnostic accuracy, whether it provides information that contributes to a correct diagnosis; (c) diagnostic impact, the extent to which CAT scanning replaces other diagnostic procedures; (d) therapeutic impact, the change in management that would not have taken place without information from the scan; and (e) outcome, the effect of CAT scan information on patient morbidity and mortality.
Undoubtedly the scanner satisfies the first three criteria, and in the care of those with head injuries there are good grounds for believing that treatment and outcome in many cases may be largely determined by the scan findings.
ADMINISTRATIVE AND ECONOMIC FACTORS
Some cost implications may be observed from the analysis of the reduced radiological work load correlated with the catchment population. Table IV shows the requirements of the special units for contrast radiology in 1974 and the effect that the introduction of a CAT scanner had on the work loads in the specialist rooms. The reductions of 50% for angiography and 900' for air studies were taken as minimum, on the basis of this series and other observations.' 5-7 The percentage use was calculated from an estimate of the maximum capacity for each room5 and tested against that achieved at Brook General Hospital during 1974.
The spare capacity of the equipment indicates that one neuroradiology department could provide the service for about four million people. Therefore, if the number of departments of neuroradiology could be reduced over several years money would be saved. Some of this money could be spent on placing scanners in general hospitals, where ready access to this tool would improve the local service, particularly in managing patients with head injuries, and also reduce the number of patients who require transfer to the central unit for specialist investigation and treatment.
The debate about high-cost medicine should take into account the level of use, clinical efficiency judged by economic criteria, and the relationships that the technology has to the other aspects of the service. The high cost of a piece of equipment alone does not justify centralisation.
Introduction
The cost of introducing computerised axial tomography (CAT) scanners into a neuroradiological service is high. Justification for this expenditure is particularly important at a time when there is widespread concern at the escalating costs of health care.
There are three aspects to the economic case for any piece of medical equipment: firstly, the effect on existing procedures and equipment-in this case the large reduction in demand for angiograms and encephalograms; secondly, the effect of the new equipment on existing services-a fall in demand for conventional neuroradiology raises the possibility that fewer departments could serve the population; and, finally, the reduction in morbidity and mortality that takes place as a result of introducing the equipment. We show here how all three aspects can be taken into account and describe an approach to evaluating the cost of CAT scanning of the brain that could also be applied to other medical equipment. The analysis consists in (a) assessing the likely demand for brain scanning and other neuroradiological services in an NHS region; (b) identifying alternative ways of meeting the demand; (c) assessing the cost implications of the alternatives and identifying the option that provides the best "return" to the community, assuming that patient outcome is not affected; and (d) assessing the value of improved treatment.
Assessing demand for neuroradiology and brain scanning An EMI brain scanner was installed in the neurosurgical unit at the Brook General Hospital in south London in February 1976. Experience since then provided a guide to changes in demand for both conventional neuroradiological procedures and brain scanning (see accompanying paper).
CONVENTIONAL NEURORADIOLOGY Table I shows the profile, before scanners were introduced, of neurosurgery, neurology, and accident services for a population of about 3-6 million people in the South-east Thames region. The introduction of CAT scanning for the immediate needs of a specialist unit reduces the need for angiograms by 50% and for air studies by 90%.1-3 Experience at the Brook General Hospital confirmed these findings. We estimated therefore that if neurosurgeons and neurologists had adequate access to scanners regional demand for angiograms would not exceed 1500 and the number of air studies required would fall to about 90. BRAIN SCANNING We assessed the demand for brain scanning in two ways, firstly by examining the demand made on a CAT scanner after installation at one hospital and calculating demand throughout the region, and, secondly, by examining the different types of demand-for example, for diagnosis, planning management-made by different specialties.
Demand after installation-(1) Demand from neurosurgical and neurological departments was calculated from the number of patients scanned at the Brook General Hospital and the hospital's catchment population. (2) Demand from accident departments was calculated on the assumption that half the 4800 people admitted for observation after a head injury throughout the region (1974 figures) would undergo scanning if facilities were available. (3) We estimated that 0-04 people per 1000 would be scanned for ophthalmology and ear, nose, and throat departments.4 A figure of 0-6 people per 1000 was calculated as the demand for scanning generated by other specialties. This figure assumed a local catchment population for the Brook General Hospital of 100 000. Service accounting examines the total costs of a specialist service and the effect that the introduction of a particular piece of equipment has on this service. Policies based on this approach are feasible for developing a new service. In a developed and complex health service, such as the NHS, however, it is difficult to implement change. Expenditure which has been based on this approach often fails to produce the predicted savings because the other changes on which the savings depend do not materialise. None the less, the approach defines the necessary changes to achieve the long-term aim of more effective health care.
Cash flow-This means (a) assessing the cash costs at today's prices and costs of installing scanners, as proposed in the options, and their likely phasing; (b) calculating potential savings from installing scanners, again in cash terms in today's money; and (c) calculating the value today (net present value) of the future savings or costs,taking into account the likelihood that the potential savings will be realised.
We selected the cash flow approach since it permits comparisons between the options on the basis of cost. Inevitably important elements in the cost equations are estimates but for the purpose of this paper the method of analysis is as important as the conclusion.
THE COSTS OF CAT SCANNING
The costs of CAT scanning have been documented fairly rigorously in the United Kingdom, North America, and Sweden. In cash terms (ignoring "notional" costs, such as depreciation) the following costs will be incurred (fig 2) . Consumable costs for angiography and pneumoencephalography will fall. Experience at the Brook General Hospital and elsewhere indicates that when a CAT scanner is available to neurosurgeons and neuroradiologists the number of angiograms will fall to half and air studies to around one-tenth of their former level in those specialist units with newly provided access to scanners. The potential savings in the cost of materials are substantial: the ratio of materials costs per test for angiography, pneumoencephalographiy, and CAT is about 11:6:1. The main savings come from film, contrast media, and disposable items such as syringes.
Maintenance on existing neuroradiological equipment will cost less. Existing maintenance costs in the region are around £140 000 a year, and annual savings of around £25 000 a unit can be expected when units are closed (savings when scanners are introduced but existing departments remain will be modest, probably around 1000 of present costs). Similarly, some existing conventional neuroradiological equipment will not need replacing: the current regional budget for such equipment is around £350 000 a year. Savings in neuroradiology space-Preliminary analysis of the space implications of the various options in the illustrative region suggests that space savings of up to 10 000 square feet might be achieved. But the space is in relatively small units, often not suitable for high-grade use-for example as pathology laboratories-but only as low-grade storage or record rooms. As such it has a potential value of perhaps £15-20 per square foot. But since hospitals generally have more than enough space this saving is not included in the cost effectiveness evaluation that follows.
Reduction in hotel costs-In principle, the introduction of CAT scanning should reduce the total number of bed days required for any selected group of patients. Many more patients can be investigated as outpatients; days of recuperation after tests are reduced; and patients (particularly those admitted directly to neurosurgery units) can be operated on more quickly. But conclusions based on crude average length of stay or similar statistics are suspect, because of the difficulty of standardising the results for other variables, such as case mix and the effect of waiting lists on doctors' behaviour. Nevertheless, an analysis of length of stay in the Brook General Hospital confirmed general US experience: mean length of stay in 57 patients with tumours after the introduction of scanning was 112 days compared with 14 5 days in 1974; in 133 patients with vascular diseases mean stay was 117 days, compared with 15 9 days in 1974. A reduction of 10-15°o in length of stay may therefore be possible. It will be important to be certain that the apparent reduction is not due to more rapid transfer of patients to their local hospital from regional units, with no overall reduction in bed days.
The bed days released can be used to accept more patients and to provide greater flexibility-more empty beds for emergency cases. Alternatively, in the region taken as a whole, it may be possible to reduce the number of beds overall. The full direct staffing and hotel costs for an occupied bed are about £10 000 a year, and if wards could be closed (or diverted to other uses) major savings would be possible. Table VII summarises the potential savings associated with the scanner deployment options for the region. These are built into the cost evaluation that follows.
Clearly there is ample room to challenge the level of the assumed savings, and particularly the probabilities attached to each. They have been reviewed by knowledgeable observers of the NHS. The important point is that the savings must be realistically assessed.
CALCULATING PRESENT VALUE OF EACH OPTION
Using the cost and savings assumptions for each option, we calculated the cash flow for each year of the expected six-year life of the additional equipment, assuming that (a) installation of the equipment would be phased over two years; (b) in year 1 only half of the running costs would be incurred and half of the potential savings from installing the additional equipment realised; (c) all "certain" savings would be realised; 900' of high probability, 700, of medium probability, and 500o of low probability savings were also included.
The scanners were assumed to have no residual value at the end of year 6.
The net cash flow for each option was then adjusted for inflation, assumed to be 90o a year over the expected six years' life of the equipment and discounted at 130% a year, to reflect the costs of funds fig 3, which indicates that an investor who wanted to achieve a 13%/ return on any investment would be prepared to pay up to £800 000 now to invest further in scanners along the lines of option 2 if he received the savings himself.
The calculations set out above take no account of a number of the important related costs and savings that will arise in evaluating these options, including transfer and provision of buildings and facilities for related specialties on a new site; closure of an accident department; adaptation or rehabilitation of old buildings; new buildings and possibly hospital closure. Not every factor enters each option. But by any standards the sums of money involved are huge when set against the cost of a scanner. Any of these factors could transform the economic attractiveness of an option and therefore should affect the choice. For example, if the consequential costs of implementing option 2 exceed £900 000 option 1 should be preferred economically. Of if the value of the improved service for head injuries in option 4 is considered to be worth more than £430 000 over six years compared with option 1 the wider deployment of scanners would be preferred. 
Value of improved treatment
The evaluation so far has taken no account of the clinical efficiency of brain scanners. It has been assumed that patient care is not affected and that all clinical decisions could be made equally well by using existing tests. A cost analysis that ignores the possibility that a clinical advance may also have value (profit and loss) is unsatisfactory. While this argument is open to challenge, it is potentially the most significant.
Some people have suggested that early diagnosis (using expensive techniques when required) will reduce future costs. Others assert that early diagnosis leads to meddlesome and unnecessary treatment, which may carry a risk of morbidity or death. For example, some clinicians believe that if the scanner were used to examine all patients with head injuries the advantage of the early detection and treatment of a significant extradural haematoma in saving lives of good quality would be more than offset by the cost of maintaining severely braindamaged patients with no hope of useful recovery. A study that was not primarily centred on the use of the scanner5 suggested that this latter fear is unfounded. There may be a net saving of good quality lives. This saving might have an important influence on which option is chosen. The recent report of the Advisory Committee on Trunk Road Assessment," which has been accepted by the British Government, indicates that the net present value of avoiding one fatal road accident now built into the cost benefit analysis of different schemes is £47 300. The committee recommends that this figure should be increased to at least £60 000; the comparable figure used in Australia is £78 000 (in 1976) and in Canada in 1975 it was £66 500.
If one life is saved annually by each scanner and that life has a net present value of £50 000 the economic attractiveness of the various options is transformed. Fig 4 shows There are other advantages to making the scanners more widely available. Scanners located in accident units will have substantial spare capacity-perhaps as much as half in options 3-5. The "spare" half could be used for body studies at marginal additional costs, since the scanner will have already been justified and even have "paid" for itself on the basis of its cost efficacy in carrying out brain studies. This should provide the financial breathing space needed to establish the clinical efficacy and cost effectiveness of whole-body scanning.
